Sunshine Biopharma
SBFMWNasdaq United States
Market cap
—
Revenue
$36.3M
#2814 by revenue
Earnings
-$5.98M
Loss-making
Shares outstanding
3,877,337
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Other share classes
Sunshine Biopharma lists more than one class of stock. Company figures above cover all classes combined.
Where these numbers come from
Share counts and financials for Sunshine Biopharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.